Skip to content

To Prevention of postpartum hemorrhage (bleeding after giving birth)in caesarean section by comparing 2 drugs that are carbetocin and oxytocin efficacy.

Comparison of oxytocin versus carbetocin in prevention of postpartum hemorrhage in Caserean section - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063620
Enrollment
150
Registered
2024-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Injection Carbetocin: Injection carbetocin 100mg diluted in 10 ml of saline IV slowly (over 1-2 mins) Control Intervention1: Injection oxytocin: Injection oxytocin 20IU in 500ml NS IV s

Sponsors

Pacific medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy women with term gestation irrespective of parity Singleton pregnancy Live baby Delivery by LSCS Any presentation

Exclusion criteria

Exclusion criteria: Twin pregnancy Intrauterine death Preeclampsia (PIH) Women with medical illness Rh incompabalitiy Any type of vaginal bleeding like placenta Previn, abruption placenta etc Abnormal placentation Hypersensitivity to carbetocin or oxytocin or misoprostol

Design outcomes

Primary

MeasureTime frame
To compare the oxytocin and carbetocin regarding effectiveness, safety during caesarean sections in women of pph As carbetocin has longer half life compared to oxytocin so carbetocin is betterTimepoint: 1 yrs

Secondary

MeasureTime frame
To compare the safety of carbetocin versus oxytocin in terms of adverse drug reaction To compare the fall in haemoglobin level & Haematocrit levelTimepoint: 1 year

Countries

India

Contacts

Public ContactAnjali Godara

Department of obstetrics and gynaecology

drrajranisharma@gmail.com9001012888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026